TARUGI, Patrizia Maria
 Distribuzione geografica
Continente #
NA - Nord America 15.773
AS - Asia 7.483
EU - Europa 6.948
SA - Sud America 1.016
AF - Africa 145
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 18
Totale 31.408
Nazione #
US - Stati Uniti d'America 15.575
SG - Singapore 2.448
GB - Regno Unito 2.445
CN - Cina 2.024
IT - Italia 1.388
HK - Hong Kong 992
BR - Brasile 782
VN - Vietnam 779
SE - Svezia 730
DE - Germania 535
FI - Finlandia 395
UA - Ucraina 337
RU - Federazione Russa 310
FR - Francia 278
KR - Corea 215
TR - Turchia 194
IN - India 191
BG - Bulgaria 145
ID - Indonesia 117
NL - Olanda 93
MX - Messico 75
AR - Argentina 73
BD - Bangladesh 70
CA - Canada 69
IQ - Iraq 64
JP - Giappone 58
PK - Pakistan 56
BE - Belgio 50
AE - Emirati Arabi Uniti 42
ES - Italia 38
ZA - Sudafrica 34
CO - Colombia 32
EC - Ecuador 31
IE - Irlanda 31
PL - Polonia 25
AT - Austria 24
CL - Cile 24
AU - Australia 23
VE - Venezuela 23
UZ - Uzbekistan 22
KE - Kenya 21
CH - Svizzera 19
MY - Malesia 19
PH - Filippine 18
SA - Arabia Saudita 18
DZ - Algeria 17
EG - Egitto 17
CZ - Repubblica Ceca 16
TN - Tunisia 16
TW - Taiwan 16
EU - Europa 15
KZ - Kazakistan 15
NP - Nepal 15
PE - Perù 15
IR - Iran 14
LT - Lituania 14
BZ - Belize 13
MA - Marocco 13
PY - Paraguay 13
UY - Uruguay 12
JO - Giordania 11
PT - Portogallo 11
CR - Costa Rica 10
ET - Etiopia 10
HU - Ungheria 10
IL - Israele 10
AZ - Azerbaigian 9
BA - Bosnia-Erzegovina 9
BO - Bolivia 9
AL - Albania 8
DO - Repubblica Dominicana 8
TH - Thailandia 8
BH - Bahrain 7
OM - Oman 7
LK - Sri Lanka 6
PS - Palestinian Territory 6
DK - Danimarca 5
GE - Georgia 5
GR - Grecia 5
JM - Giamaica 5
KG - Kirghizistan 5
KW - Kuwait 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
PR - Porto Rico 4
QA - Qatar 4
RO - Romania 4
EE - Estonia 3
KH - Cambogia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
MM - Myanmar 2
NE - Niger 2
Totale 31.374
Città #
Southend 1.766
Fairfield 1.667
Singapore 1.599
Santa Clara 1.485
Ashburn 1.446
Woodbridge 1.149
Hong Kong 969
Houston 891
Jacksonville 702
Hefei 700
Chandler 664
Seattle 638
Wilmington 615
San Jose 565
Ann Arbor 522
Cambridge 489
Dearborn 403
Nyköping 396
London 351
Beijing 350
Helsinki 282
Modena 252
Ho Chi Minh City 242
Los Angeles 232
The Dalles 206
Seoul 202
Chicago 201
Hanoi 174
Council Bluffs 166
San Diego 151
Princeton 149
Sofia 139
New York 135
Milan 123
Eugene 110
Lauterbourg 107
Buffalo 104
Moscow 96
Rome 94
Salt Lake City 88
Shanghai 82
Jakarta 81
Dallas 79
Izmir 74
Columbus 70
Des Moines 68
São Paulo 64
Falls Church 61
Grafing 51
Da Nang 46
Elk Grove Village 45
Munich 43
Orem 42
Bremen 39
Frankfurt am Main 39
Naples 37
Rio de Janeiro 37
Boardman 34
Brussels 34
Tokyo 34
Atlanta 30
Mexico City 30
Tampa 30
Nanjing 29
Redwood City 29
Dublin 28
Detroit 24
Haiphong 24
Baghdad 23
Brooklyn 23
Chennai 23
Guangzhou 23
Kunming 23
Bologna 22
Nuremberg 22
Norwalk 21
Tashkent 21
Belo Horizonte 20
Turin 20
San Mateo 19
Toronto 19
Kent 18
Padova 18
Paris 18
Biên Hòa 17
Florence 17
Kilburn 17
Lahore 17
Phoenix 17
Verona 17
Montreal 16
San Francisco 16
Warsaw 16
Wuhan 16
Buenos Aires 15
Manchester 15
Poplar 15
Redondo Beach 15
Reggio Emilia 15
Dulles 14
Totale 22.492
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.143
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 521
Low-density lipoprotein (LDL) receptor/transferrin fusion protein: in vivoproduction and functional evaluation as a potential therapeutic tool forlowering plasma LDL cholesterol. 468
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 451
A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol 399
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 364
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 358
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 357
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 345
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 337
Altered mRNA splicing in lipoprotein disorders 336
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 332
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 325
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 321
The Janus-faced manifestations of homozygous familial hypobetalipoproteinemia due to apolipoprotein B truncations 318
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 317
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 310
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 310
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 309
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum(PXE). 308
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 305
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 304
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 302
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins. 298
Identification of patients with abetalipoproteinemia and homozygous familial hypobetalipoproteinemia in Tunisia 297
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 292
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 288
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 282
Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B 282
Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol–diabetes connection? A systematic review of literature 282
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 280
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 275
Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis 274
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 273
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 273
Structure-function analyses of microsomal triglyceride transfer protein missense mutations in abetalipoproteinemia and hypobetalipoproteinemia subjects 271
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 270
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 269
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 269
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: A comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia. 265
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 265
Improvement in the high-performance liquid chromatography malondialdehyde level determination in normal human plasma 264
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 263
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 259
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 256
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. 254
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 253
A 54-year-old diabetic man with low serum cholesterol. 252
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 251
Flow-mediated dilation, carotid wall thickness and HDL function in subjects with hyperalphalipoproteinemia 250
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 249
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 247
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 246
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 244
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 243
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia 242
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 242
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 242
Plasma non-cholesterol sterols in primary hypobetalipoproteinemia. 240
Pediatric gallstone disease in familial hypobetalipoproteinemia 236
PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia 235
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 235
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 234
Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B. 233
A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia. 231
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 229
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 229
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 227
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 226
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia. 225
Phenotypic variability in 4 homozygous familial hypercholesterolemia siblings compound heterozygous for LDLR mutations 223
The protective effect on Cu2+- and AAPH-mediated oxidation of human low-density lipoproteins depends on glycosaminoglycan structure 220
Influence of chondroitin sulfate charge density, sulfate group position, and molecular mass on Cu2+-mediated oxidation of human low-density lipoproteins: Effect of normal human plasma-derived chondroitin sulfate 219
Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. 219
Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide 219
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 214
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 213
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia 213
The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux 212
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 212
Synthesis and secretion of apolipoprotein A-I by chick skin. 212
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 211
Cholesterol synthesis in freshly isolated human leukocytes. 208
Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function 208
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 208
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 207
Exome Sequencing in Suspected Monogenic Dyslipidemias 205
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome 204
Familial hypobetalipoproteinemia: analysis of three Spanish cases with two new mutations in the APOB gene. 201
Chemical and morphological changes of rat plasma lipoproteins after a prolonged administration of diets containing olive oil and cholesterol. 200
Dyslipidemia in rats with hypothyroidism 199
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 198
Abetalipoproteinemia in an infant with severe clinical phenotype and a novel mutation 194
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 190
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 190
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 189
Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick. 189
Mutation screening of the Otop1 gene in familial benign positional paroxysmal vertigo 187
Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. 181
In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia 180
Totale 27.007
Categoria #
all - tutte 121.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021757 0 0 0 0 0 0 0 0 0 380 206 171
2021/20222.572 151 283 219 191 56 213 151 106 282 215 454 251
2022/20232.204 257 218 159 179 252 351 40 196 294 46 131 81
2023/20241.654 73 83 149 147 301 148 131 187 74 120 49 192
2024/20255.494 184 50 118 376 1.049 849 444 333 501 241 612 737
2025/20269.062 726 466 932 1.027 1.527 741 1.346 553 951 793 0 0
Totale 31.593